Replies to post #242670 on Elite Pharmaceuticals Inc (ELTP)

[Gman24]

It sounded to me that Nasrat isn't exactly happy with the epic agreement and both sides might be playing hard ball. Nasrat expanding manufacturing space and the expansion of the workforce tells me that Elite is now trying to go it alone at least on the generic side along with their new partner SunGen.

If negotiations don't work out in favor of Elite with PuraCap/HumanWell connection soon. I see Nasrat shopping for a new Big Pharma deal. Just speculation but he was adamant about a lot more R&D and the need to raise money.

IMO.. with positive BE study new investors will connect the dots here along with the catalyst/ filings we have before summer. But in any case with all the delays that the FDA has thrown at us 2018 is sure looking bright. I realize that is not what some want to or need to hear but it is no fault of Nasrat and simply part of investing into Pharma.

No one and I mean no one has promised anything for sure. I challenge anyone to through up a link to the contrary. Of course many of us thought and hoped things would move at a more rapid pace. But again this is Pharma. I can and will wait for one more year to be debt and financial free. GLTA

[Couch]

In the end, I believe stock will be stuck for few months and start to move north in the summer and from there won't retreat.

I'd say investors traders etc., have more like 6-9 months prior to the PPS moving north and not retreating. I thought the CC was a solid one as well. However, the question is how long is it going to take for Elite to launch another drug and garner revenue off the next drug?

Nasrat even said he is moving Dantrolene an Loxapine to Elite to be manufactured. More time.

I like what I'm seeing with Nasrat adding lucrative Andas.

IMO a great time to continue to buy on any dips.